Bristol-Myers Squibb (BMY) Confirms ISS and Glass Lewis Recommend Shareholders Vote for Proposed Merger with Celgene (CELG)

March 29, 2019 11:14 AM
Bristol-Myers Squibb Company (NYSE: BMY) today announced that independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles